| PERIOD ENDING | 4-Apr-09 | 3-Jan-09 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 1,725,474 | 1,912,150 | 2,206,627 | 1,677,482 | | Cost of Revenue | 996,640 | 1,099,210 | 1,227,577 | 942,763 | | | Gross Profit | 728,834 | 812,940 | 979,050 | 734,719 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 567,386 | 633,137 | 627,839 | 570,863 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 161,448 | 179,803 | 351,211 | 163,856 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,014 | (2,634) | (515) | 4,615 | | Earnings Before Interest And Taxes | 163,462 | 177,169 | 350,696 | 168,471 | | Interest Expense | 22,015 | 24,534 | 24,310 | 23,007 | | Income Before Tax | 141,447 | 152,635 | 326,386 | 145,464 | | Income Tax Expense | 41,013 | 36,772 | 92,511 | 41,486 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 100,434 | 115,863 | 233,875 | 103,978 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 100,434 | 115,863 | 233,875 | 103,978 | | Preferred Stock And Other Adjustments | 505 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $100,939 | $115,863 | $233,875 | $103,978 |
|
0.45% Nasdaq 
0.20%
Income Statement
